NCT04522323 2025-07-25A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell CarcinomaMedImmune LLCPhase 1 Active not recruiting67 enrolled
NCT03324373 2025-04-24Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)University of IowaPhase 1 Completed11 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT03006887 2021-05-20Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid TumorsEisai Inc.Phase 1 Completed6 enrolled 27 charts
NCT02454478 2019-03-19Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)Eisai Inc.Phase 1 Completed7 enrolled 17 charts
NCT02915172 2017-06-26Lenvatinib and Capecitabine in Patients With Advanced MalignanciesM.D. Anderson Cancer CenterPhase 1 Withdrawn